HUTCHMED Highlights First Presentation Of Results Of The SAVANNAH Global Phase II Trial Of Savolitinib Plus TAGRISSO® At The 2022 WCLC Annual Meeting

Press/Media

Period12 Jul 2022

Media coverage

1

Media coverage

  • TitleHUTCHMED Highlights First Presentation Of Results Of The SAVANNAH Global Phase II Trial Of Savolitinib Plus TAGRISSO® At The 2022 WCLC Annual Meeting
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date12/07/22
    PersonsSeok Lee
View all 1
View less